Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles modified nanoprecipitation method

Drug Development and Industrial Pharmacy

Volumn 35, Issue 11, 2009, Pages 1375-1383

  Niu, Xiuming ^a   Zou, Weiwei ^b   Liu, Chunxi ^b   Zhang, Na ^b   Fu, Chunhua ^a  

^a SHANDONG MEDICAL COLLEGE   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Double emulsion solvent evaporation method; Gene therapy; Modified nanoprecipitation method; Nonviral gene delivery system; PLGA nanoparticles

Indexed keywords

DEOXYRIBONUCLEASE I; DNA; ENHANCED GREEN FLUORESCENT PROTEIN; LIPOFECTAMINE; NANOPARTICLE; PLASMID DNA; POLYGLACTIN;

ARTICLE; CELL VIABILITY; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG RELEASE; EMULSION; ENCAPSULATION; EVAPORATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NANOPRECIPITATION; NANOTECHNOLOGY; PARTICLE SIZE; PRECIPITATION; ZETA POTENTIAL;

CELL LINE, TUMOR; CELL SURVIVAL; CHEMICAL PRECIPITATION; DEOXYRIBONUCLEASE I; DNA; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; ELECTROPHORESIS, AGAR GEL; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; HUMANS; LACTIC ACID; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; PLASMIDS; POLYGLYCOLIC ACID; SOLUBILITY; SURFACE PROPERTIES; TRANSFECTION;

EID: 70350342537     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639040902939221     Document Type: Article

References (37)

1. Solly SK, Trajcevski S, Frisén C, Holzer GW, Nelson E, Clerc B, et al. (2003). Replicative retroviral vectors for cancer gene therapy. Cancer Gene Ther, 10:30-39
2. Roy I, Holle L, Song W, Holle E, Wagner T, Yu X. (2002). Efficient translocation and apoptosis induction by adenovirus encoded VP22-p53 fusion protein in human tumor cells in vitro. Anticancer Res, 22:3185-3189
3. Kichler A, Leborgne C, Coeytaux E, Danos O. (2001). Polyethylenimine- mediated gene delivery: A mechanistic study. J Gene Med, 3:135-144
4. Farrell LL, Pepin J, Kucharski C, Lin X, Xu Z, Uludag H. (2007). A comparison of the effectiveness of cationic polymers poly-L-lysine (PLL) and polyethylenimine (PEI) for non-viral delivery of plasmid DNA to bone marrow stromal cells (BMSC). Eur J Pharm Biopharm, 65:388-397
5. Basarkar A, Devineni D, Palaniappan R, Singh J. (2007). Preparation, characterization, cytotoxicity and transfection efficiency of poly(DL-lactide-co-glycolide) and poly(DL-lactic acid) cat-ionic nanoparticles for controlled delivery of plasmid DNA. Int J Pharm, 343:247-254
6. Brown MD, Schätzlein AG, Uchegbu IF. (2001). Gene delivery with synthetic (non viral) carriers. Int J Pharm, 229:1-21.
7. Leong KW, Mao HQ, Truong-Le VL, Roy K, Walsh SM, August JT. (1998). DNA-polycation nanospheres as non-viral gene delivery vehicles. J Control Release, 53:183-193
8. Li SD, Huang L. (2007). Non-viral is superior to viral gene delivery. J Control Release, 123:181-183
9. Gao X, Kim KS, Liu D. (2007). Nonviral gene delivery: What we know and what is next. AAPS J, 9:E92-104.
10. Lobenberg R, Araujo L, Kreuter J. (1997). Body distribution of azidothymidine bound to nanoparticles after oral administration. Eur J Pharm Biopharm, 44:127-132
11. Suri SS, Fenniri H, Singh B. (2007). Nanotechnology-based drug delivery systems. J Occup Med Toxicol, 2:16.
12. Díez S, Tros de Ilarduya C. (2006). Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery. Eur J Pharm Biopharm, 63:188-197
13. Panyam J, Zhou WZ, Prabha S, Sahoo SK, Labhasetwar V. (2002). Rapid endo-lysosomal escape of poly(DL-lactide-co-gly-colide) nanoparticles: Implications for drug and gene delivery. FASEBJ, 16:1217-1226
14. Jones DH, Corris S, McDonald S, Clegg JC, Farrar GH. (1997). Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine, 15:814-817
15. Mok H, Park TG. (2008). Direct plasmid DNA encapsulation within PLGA nanospheres by single oil-in-water emulsion method. Eur J Pharm Biopharm, 68:105-111
16. Evans RK, Xu Z, Bohannon KE, Wang B, Bruner MW, Volkin DB. (2000). Evaluation of degradation pathways for plasmid DNA in pharmaceutical formulations via accelerated stability studies. J Pharm Sci, 89:76-87.
17. Remaut K, Sanders NN, Fayazpour F, Demeester J, De Smedt SC. (2006). Influence of plasmid DNA topology on the transfection properties of DOTAP/DOPE lipoplexes. J Control Release, 115:335-343
18. Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. (1989). Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm, 55:R1-4.
19. Sternling CV, Scriven LE. (1959). Interfacial turbulence: Hydrodynamic instability and the Marangoni effect. AIChE J, 5:514-523
20. Quintanar-Guerrero D, Allémann E, Fessi H, Doelker E. (1998). Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm, 24:1113-1128
21. Barichello JM, Morishita M, Takayama K, Nagai T. (1999). Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev Ind Pharm, 25:471-476
22. Yoo HS, Choi HK, Park TG. (2001). Protein-fatty acid complex for enhanced loading and stability within biodegradable nanoparticles. J Pharm Sci, 90:194-201.
23. Subrahmanyam M, Kaneco S, Alonso-Vante N, Labhasetwar V, Bonadio J, Goldstein SA, et al. (1999). Gene transfection using biodegradable nanospheres: Results in tissue culture and a rat osteotomy model. Colloids Surf B Biointerfaces, 16:281-290
24. Oster CG, Wittmar M, Bakowsky U, Kissel T. (2006). DNA nano-carriers from biodegradable cationic branched polyesters are formed by a modified solvent displacement method. J Control Release, 111:371-381
25. del Pozo-Rodríguez A, Delgado D, Solinís MA, Gascón AR, Pedraz JL. (2007). Solid lipid nanoparticles: Formulation factors affecting cell transfection capacity. Int J Pharm, 339:261-268
26. Li Y, Pei Y, Zhang X, Gu Z, Zhou Z, Yuan W, et al. (2001). PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats. J Control Release, 71:203-211 (Pubitemid 32234381)
27. Shi K, Cui F, Yamamoto H, Kawashima Y. (2008). Investigation of drug loading and in vitro release mechanisms of insulin-lauryl sulfate complex loaded PLGA nanoparticles. Pharmazie, 63:866-871
28. Chognot D, Léonard M, Six JL, Dellacherie E. (2006). Surfac-tive water-soluble copolymers for the preparation of controlled surface nanoparticles by double emulsion/solvent evaporation. Colloids Surf B Biointerfaces, 51:86-92.
29. Prabha S, Zhou WZ, Panyam J, Labhasetwar V. (2002). Size-dependency of nanoparticle-mediated gene transfection: Studies with fractionated nanoparticles. Int J Pharm, 244:105-115
30. Ando S, Putnam D, Pack DW, Langer R. (1999). PLGA micro-spheres containing plasmid DNA: Preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. J Pharm Sci, 88:126-130
31. Zhuang FF, Liang R, Zou CT, Ma H, Zheng CX, Duan MX. (2002). High efficient encapsulation of plasmid DNA in PLGA microparticles by organic phase self-emulsification. J Biochem Biophys Methods, 52:169-178
32. Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. (1999). PLGA nanoparticles prepared by nanoprecipitation: Drug loading and release studies of a water soluble drug. J Control Release, 57:171-185
33. Bilati U, Allémann E, Doelker E. (2005). Nanoprecipitation versus emulsion-based techniques for the encapsulation of proteins into biodegradable nanoparticles and process-related stability issues. AAPS PharmSciTech, 6:E594-604.
34. Peltonen L, Aitta J, Hyvönen S, Karjalainen M, Hirvonen J. (2004). Improved entrapment efficiency of hydrophilic drug substance during nanoprecipitation of poly(l)lactide nanoparticles. AAPS PharmSciTech, 5:E16.
35. Barry ME, Pinto-González D, Orson FM, McKenzie GJ, Petry GR, Barry MA. (1999). Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection. Hum Gene Ther, 10:2461-2480
36. Panyam J, Labhasetwar V. (2003). Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev, 55:329-347
37. Zhang S, Zhao B, Jiang H, Wang B, Ma B. (2007). Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release, 123:1-10.